Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Italian researchers launch major study to map advanced lung cancer

NCT ID NCT06076005

First seen Nov 01, 2025

Summary

This study is collecting detailed information from 1,000 people newly diagnosed with advanced (stage IV) lung cancer in Italy. Researchers will look at patient demographics, tumor types, genetic markers, and imaging results to better understand the disease at diagnosis. The goal is to identify patterns that could improve future diagnosis and treatment approaches.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER STAGE IV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Interventional Pulmonology Division - Fondazione Policlinico Universitario A. Gemelli IRCCS

    RECRUITING

    Roma, Italy

    Contact Email: •••••@•••••

  • Istituto Nazionale Tumori Regina Elena

    NOT_YET_RECRUITING

    Roma, Italy

    Contact

  • Medical Oncology Division - Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    NOT_YET_RECRUITING

    Roma, Italy

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

This study could help doctors better understand the features of advanced lung cancer in Italian patients, potentially guiding future research and personalized care.

What could go wrong

This is an observational study, not a treatment trial, so it will not directly improve patient outcomes. Results may not apply to other populations.

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.